Skip to main content

Diabetes

Featured Article
“Research indicates that metformin may exert the various clinical effects via different signaling pathways; however, the precise mechanisms have not yet been determined and research is ongoing,” says…
“This cohort also establishes a baseline against which to assess the impact of national or regional strategies to prevent diabetes in veterans,” the authors wrote. “It also provides an analytic…

Insights

“The SGLT2i are an expensive group of drugs in comparison to other goal-directed medical therapies for HfrEF, says Mark Munger, PharmD. “Perhaps this data might assist in formulary decisions and oversight use of these medications.”
“Research indicates that metformin may exert the various clinical effects via different signaling pathways; however, the precise mechanisms have not yet been determined and research is ongoing,” says Yvette C. Terrie, BS Pharm, RPh, consultant…
As frontline health care providers, pharmacists are in a pivotal position to act as patient identifiers, patient educators and patient advocates especially for those at risk for or with diabetes.
Tayla Rose, PharmD, MEd, RPh, BCACP, CDE, assistant clinical professor in the Department of Pharmacy and Health Systems Sciences at Northeastern University School of Pharmacy, explains why providers should be mindful of the high cost of diabetes…

Interactive Features

Bob Maguire, BioLab Sciences, and Charles Pollak, Red One Medical, discuss their recent partnership and highlight a treatment option for veterans with diabetic foot ulcers, which impacts roughly 75,000 veterans.
Does hepatitis C treatment success improve insulin resistance in patients with diabetes?
Back to Top